Ellis Investment Partners’s Novartis NVS Stock Holding History

Ellis Investment Partners’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,895	Closed	-$144K	–	556
2022 Q3	$144K	Sell	1,895 -500	-21%	-$41.4K	0.04%	241
2022 Q2	$202K	Buy	2,395 +1,686	+238%	+$148K	0.05%	195
2022 Q1	$62K	Sell	709 -176	-20%	-$15.2K	0.01%	395
2021 Q4	$77K	Hold	885	–	–	0.02%	364
2021 Q3	$72K	Hold	885	–	–	0.02%	355
2021 Q2	$80K	Hold	885	–	–	0.02%	337
2021 Q1	$76K	Hold	885	–	–	0.02%	335
2020 Q4	$84K	Hold	885	–	–	0.03%	308
2020 Q3	$76K	Hold	885	–	–	0.03%	294
2020 Q2	$77K	Hold	885	–	–	0.03%	291
2020 Q1	$71K	Buy	885 +176	+25%	+$15.7K	0.03%	236
2019 Q4	$67K	Hold	709	–	–	0.02%	299
2019 Q3	$61K	Hold	709	–	–	0.02%	309
2019 Q2	$65K	Buy	+709	New	+$60K	0.02%	296

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Ellis Investment Partners's NVS Position: Q4 2022 in Review

Ellis Investment Partners sold out of Novartis (NVS) in Q4 2022, closing a stake of 1,895 shares — an estimated $144K sold.

Ellis Investment Partners first reported a position in NVS in Q2 2019 and held it in 14 quarters. The position peaked at $202K in Q2 2022. 1,182 funds tracked by Wall St. Rank hold NVS as of Q4 2022.

Ellis Investment Partners reported no remaining Novartis position as of Q4 2022 after selling out during the quarter.
Ellis Investment Partners sold 1,895 Novartis shares in Q4 2022, an estimated $144K.
Ellis Investment Partners first reported a position in Novartis in Q2 2019 and held it in 14 quarters.
Ellis Investment Partners's Novartis position peaked at $202K in Q2 2022.
1,182 funds tracked by Wall St. Rank held Novartis as of Q4 2022.

Based on Ellis Investment Partners's 13F filing for Q4 2022, filed 31 Jan 2023.